Feasibility Study of the iVEAcare Neuromodulation System for the Treatment of Drug-Resistant Epilepsy | MicrobiomeTrials← Back to trialsNCT07640191
Feasibility Study of the iVEAcare Neuromodulation System for the Treatment of Drug-Resistant Epilepsy
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2026-06Est. Completion: 2027-06
Enrollment target: 30 participants Other microbiome trials you might be interested in
Mesial Temporal Lobe Epilepsy
This clinical trial is designed to test whether a single image-guided intracerebral administration of inhibitory nerve c…
Birmingham, United StatesEst. completion Feb 2029
EpilepsyIdiopathic Generalized EpilepsyGeneralized Tonic Clonic Seizure
To demonstrate that the RNS System for thalamic stimulation is safe and effective as an adjunctive therapy for the reduc…
Birmingham, United StatesCompleted Apr 4, 2025